SONOSCAPE(SZ:300633)2023-10-27 04:40Financial Performance - In the first three quarters of 2023, the company achieved a revenue of 1.468 billion, representing a year-on-year growth of 17.31% [2] - Net profit for the same period was 321 million, with a year-on-year increase of 30.65%, maintaining a profit growth rate higher than revenue growth [2] - The third quarter saw stable revenue due to external environmental factors, while expenses increased due to surgical team and travel costs, leading to a slight decline in net profit [2] Product Development - The HD-580 series endoscope is a significant upgrade from the HD-550, featuring enhanced image quality, contrast, signal-to-noise ratio, and electronic staining algorithms [3] - The new model supports advanced imaging modes and has improved light sensitivity and response time, positioning it for a higher market segment compared to the HD-550 [3] Market Outlook - The company anticipates a recovery in the fourth quarter due to traditional seasonal demand, with expectations of improved sales as external factors stabilize [3] - The ultrasound business faced challenges in Q3 due to market saturation, while the endoscope segment continued to grow at a high rate [3] - The company believes that the industry environment will favor leading brands, enhancing their competitive position in the market [3] International Business - The company has a stable overseas sales presence in nearly 130 countries, with significant sales in Europe and South America [4] - The overseas business is expected to continue stable growth, supported by the establishment of marketing subsidiaries in countries like India, the Netherlands, Russia, and Germany [4]